Table 6 Resistance trend in isolates of Salmonella spp. over 5 years in Kuwait
From: Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States
| Antibiotic | Percentage (%) of resistant isolates in: | ||||
|---|---|---|---|---|---|
| 1999 (n = 216) | 2000 (n = 215) | 2001 (n = 129) | 2002 (n = 167) | 2003 (n = 165) | |
| Amikacin | 0 | 0 | 0 | 0 | 0 |
| Ampicillin | 6 | 12 | 7 | 25 | 26 |
| Amoxicillin-clavulanate | 5 | 10 | 7 | 2 | 0 |
| Cefotaxime | 0 | 1 | 0 | 1 | 0 |
| Ceftriaxone | 0 | 1 | 0 | 2 | 0 |
| Cefuroxime | 1 | 1 | 0 | 27 | 41 |
| Cephalexin | 2 | 10 | 37 | 57 | 50 |
| Chloramphenicol | 8 | 21 | 0 | 18 | 18 |
| Ciprofloxacin | 0 | 0 | 14 | 10 | 16 |
| TMP/SMX | 8 | 8 | 10 | 20 | 20 |
| Gentamicin | 6 | 1 | 0 | 42 | 42 |
| Imipenem | 0 | 0 | 0 | 0 | 0 |
| Meropenem | 0 | 0 | 0 | 0 | 0 |
| Piperacillin | 6 | 13 | 13 | 23 | 25 |
| Piperacillin/tazobactam | 0 | 0 | 0 | 0 | 0 |